Incretin-based Drugs Market Share

Statistics for the 2023 & 2024 Incretin-based Drugs market share, created by Mordor Intelligence™ Industry Reports. Incretin-based Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research Synthetic Compounds Research Incretin-based Drugs Market Market Share

Market Share of Incretin-based Drugs Industry

The incretin-based drugs market is moderately competitive. Some key players are AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Eli Lilly, GlaxoSmithKline PLC., Merck Sharp & Dohme Corp., Novartis AG, Novo Nordisk, and Sanofi SA, among others, hold the major share in the market.

Incretin Based Drugs Market Leaders

  1. AstraZeneca

  2. Novo Nordisk

  3. Eli Lilly

  4. Novartis AG

  5. Merck & Co. Inc.

*Disclaimer: Major Players sorted in no particular order

Incretin-based Drugs Market Concentration

Incretin-based Drugs Report Snapshots

Incretin-based Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)